Advancing Care in Acne and Rosacea

Acne and rosacea remain among the most common and often most nuanced conditions encountered in dermatologic practice. Despite their prevalence, both diseases continue to evolve in how we understand their pathophysiology, address disparities in care, and integrate emerging therapies into everyday clinical decision-making. In this issue, we are pleased to present a collection of articles that reflect the dynamic and multifaceted nature of treating these conditions today.

A central theme across these articles is the importance of individualized, patient-centered care. In our roundtable discussion on isotretinoin, we explore how evolving clinical practices are shaping prescribing patterns, monitoring, and counseling. While isotretinoin remains a cornerstone for severe acne, variability in real-world use creates the need for thoughtful, evidence-informed decision-making. 

This issue also examines emerging technologies that are reshaping treatment paradigms. As highlighted in the discussion with Dr. Emmy Graber, lasers and light-based therapies are no longer reserved for refractory cases, but rather are increasingly integrated earlier in acne and rosacea management, offering new options for patients seeking alternatives or adjuncts to traditional pharmacologic therapies. 

Equally important is addressing disparities and optimizing outcomes in diverse patient populations. The article on acne in skin of color underscores the heightened risk of postinflammatory hyperpigmentation, differences in treatment patterns, and the critical role of early, proactive, and barrier-supportive care. 

Finally, we revisit foundational therapies with a critical lens. Benzoyl peroxide remains indispensable in acne treatment, yet recent data on benzene formation remind us of the importance of product selection, storage, and ongoing safety monitoring while maintaining a balanced risk-benefit perspective. 

Together, these contributions highlight both enduring principles and emerging innovations in acne and rosacea care. We hope this issue provides practical insights to support your clinical practice and inspires continued dialogue as our field advances. 

—Julie C. Harper, MD, FAAD;
and Hilary E. Baldwin, MD, FAAD

Guest Medical Editors